IP Library › Granted Patent US 8,034,635
Granted Patent B2
US 8,034,635 · App. 12/326,547 · Granted Oct 11, 2011

Methods of donor specific crossmatching

Assignee: AbSorber AB
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,034,635
App. No.
12/326,547
Granted
Oct 11, 2011
Kind
B2
Abstract

The detection of endothelial cell antibodies has been proven clinically important for successful organ transplantation. Disclosed are methods of isolating endothelial cell antibodies and methods for donor-specific crossmatching.

Claims (15)

1. A method of cross-matching a donor and a recipient comprising:

(a) providing a donor sample containing, or suspected of containing, a precursor endothelial cell;

(b) contacting the donor sample with a detection reagent to isolate the endothelial cell under conditions where the precursor endothelial cell and the detection reagent are capable of forming a complex;

(c) separating said complex from the sample, thereby isolating said precursor endothelial cell from said biological sample;

wherein the isolated precursor endothelial cell is CD34 negative and CD14 positive; and

(d) screening a recipient sample for a reactivity with the isolated precursor endothelial cell wherein no reactivity of the recipient sample with the isolated precursor endothelial cell indicates compatibility between the donor and recipient.

2. The method of claim 1 , wherein the detection reagent is a ligand for an endothelial cell surface receptor.

3. The method of claim 2 , wherein said ligand is angiopoietin or VEGF.

4. The method of claim 1 , wherein the detection reagent is an antibody, or Fab or Fv fragment thereof.

5. The method of claim 4 , wherein the antibody is specific against an endothelial cell receptor.

6. The method of claim 5 , wherein the endothelial cell receptor is Tie-2 or VEGFR-1.

7. The method of claim 4 , wherein the antibody or Fab or Fv fragment thereof is attached to a solid support.

8. The method of claim 7 , wherein the solid support is a non-magnetic, magnetic or a paramagnetic bead.

9. The method of claim 1 , wherein the isolated endothelial cell is Tie-2 positive or VEGFR-1 positive.

10. The method of claim 1 , wherein the donor sample or recipient sample is selected from the group consisting of whole blood, sera, tissue, peripheral blood, mononuclear cells, and leucapherisate.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 3, 2017
From: ABSORBER AB
To: OLERUP SSP AB
Reel/Frame 041166/0459 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 17, 2009
From: HOLGERSSON, SUCHITRA SUMITRAN
To: ABSORBER AB.
Reel/Frame 022560/0411 →
Continuity (3)
Division 10439666 · May 16, 2003
Provisional Application 60381033 · May 16, 2002
Related Publication 20090142780A1 · Jun 4, 2009